CR GROUP L.P. sold 60.2% of their position (5.39M shares) of T2 BIOSYSTEMS, INC. on the open market
Open‑market sale worth $1.08M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 9/28/2023ACC: 0001209191-23-050732
-5.39M
Net shares
Net seller
$1.08M
Total sold
4
Open market trades
0B · 4S
4
Total transactions
5.39M disposed
Non-Derivative Transactions4
Common Stock
Indirect
Shares
−2.16M
Price / share
$0.20
Trade value
$432.85K
% of position
29.1%
9/26/2023
7.41M→5.25M
Common Stock
Indirect
Shares
−1.34M
Price / share
$0.20
Trade value
$269.54K
% of position
29.1%
9/26/2023
4.61M→3.27M
Common Stock
Indirect
Shares
−431.34K
Price / share
$0.20
Trade value
$86.57K
% of position
29.1%
9/26/2023
1.48M→1.05M
Common Stock
Indirect
Shares
−1.46M
Price / share
$0.20
Trade value
$293.39K
% of position
29.1%
9/26/2023
5.02M→3.56M
Total
Net shares
−5.39M
Net value
-$1.08M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/26/2023 | S · Sale | −2.16M | $0.20 | $432.85K | 29.1% | 7.41M | 5.25M |
| Common Stock Indirect | 9/26/2023 | S · Sale | −1.34M | $0.20 | $269.54K | 29.1% | 4.61M | 3.27M |
| Common Stock Indirect | 9/26/2023 | S · Sale | −431.34K | $0.20 | $86.57K | 29.1% | 1.48M | 1.05M |
| Common Stock Indirect | 9/26/2023 | S · Sale | −1.46M | $0.20 | $293.39K | 29.1% | 5.02M | 3.56M |
| Total | −5.39M | -$1.08M | ||||||
Derivative Transactions0
No derivative transactions reported